JP2020513050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513050A5 JP2020513050A5 JP2019553932A JP2019553932A JP2020513050A5 JP 2020513050 A5 JP2020513050 A5 JP 2020513050A5 JP 2019553932 A JP2019553932 A JP 2019553932A JP 2019553932 A JP2019553932 A JP 2019553932A JP 2020513050 A5 JP2020513050 A5 JP 2020513050A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- item
- composition
- alkyl
- quencher
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C(C(C(NCCO*)=O)NC(C(*)NC([U]*)=O)=O)I Chemical compound *C(C(C(NCCO*)=O)NC(C(*)NC([U]*)=O)=O)I 0.000 description 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762478639P | 2017-03-30 | 2017-03-30 | |
| US62/478,639 | 2017-03-30 | ||
| PCT/US2018/025567 WO2018183960A1 (en) | 2017-03-30 | 2018-03-30 | Protease-activated contrast agents for in vivo imaging |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513050A JP2020513050A (ja) | 2020-04-30 |
| JP2020513050A5 true JP2020513050A5 (cg-RX-API-DMAC7.html) | 2021-05-06 |
| JP7149614B2 JP7149614B2 (ja) | 2022-10-07 |
Family
ID=63678348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553932A Active JP7149614B2 (ja) | 2017-03-30 | 2018-03-30 | in vivo画像化のためのプロテアーゼ活性化コントラスト剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11828752B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3601261A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7149614B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102669535B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110678460A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018183960A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107406872B (zh) * | 2015-01-22 | 2023-03-28 | 里兰斯坦福初级大学理事会 | 用于标记动物组织的化合物、组合物及其应用 |
| WO2022203930A1 (en) * | 2021-03-24 | 2022-09-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Fluorogenic cyanine carbamates |
| CN116199675B (zh) * | 2021-11-30 | 2024-08-20 | 中国科学院大连化学物理研究所 | 一类罗丹明荧光淬灭剂及其合成和应用 |
| CN116199662B (zh) * | 2021-11-30 | 2024-10-11 | 中国科学院大连化学物理研究所 | 一种可见光和近红外光罗丹明荧光淬灭剂及其合成和应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL60888A (en) | 1978-06-16 | 1984-07-31 | Yeda Res & Dev | Substrates and process for the quantitative assay of enzymes |
| US5055451A (en) | 1986-12-22 | 1991-10-08 | Syntex Inc. | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
| WO1996041638A1 (en) | 1995-06-13 | 1996-12-27 | Sanofi Winthrop, Inc. | Calpain inhibitors for the treatment of neurodegenerative diseases |
| US6544951B2 (en) | 1998-07-02 | 2003-04-08 | Idun Pharmaceuticals, Inc. | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| US20020052323A1 (en) | 2000-08-30 | 2002-05-02 | Jinhai Wang | Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents |
| GB0112868D0 (en) * | 2001-05-25 | 2001-07-18 | Secr Defence | Detection system |
| US7303741B2 (en) | 2002-09-23 | 2007-12-04 | General Electric Company | Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism |
| JP2008522624A (ja) | 2004-12-09 | 2008-07-03 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘミアスタリン(hemiasterlin)アナログを使用する癌治療におけるチューブリンのアイソタイプのスクリーニング |
| US8968700B2 (en) | 2005-08-11 | 2015-03-03 | The Board Of Trustees Of The Leland Stanford Junior University | Imaging of protease activity in live cells using activity based probes |
| WO2008104271A2 (en) | 2007-02-28 | 2008-09-04 | Sanofi-Aventis | Imaging probes |
| CN101652149B (zh) | 2007-02-28 | 2012-11-14 | 塞诺菲-安万特股份有限公司 | 成像探针 |
| MY148484A (en) | 2007-08-03 | 2013-04-30 | Sanofi Aventis | Caspase imaging probes |
| US20090214436A1 (en) | 2008-02-18 | 2009-08-27 | Washington University | Dichromic fluorescent compounds |
| US8343458B2 (en) | 2008-04-03 | 2013-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Probes for in vivo targeting of active cysteine proteases |
| US9155471B2 (en) | 2009-05-27 | 2015-10-13 | Lumicell, Inc'. | Methods and systems for spatially identifying abnormal cells |
| WO2012021800A2 (en) | 2010-08-13 | 2012-02-16 | Banyan Biomarkers | Caspase inhibitors as therapeutics for neural and organ injury and imaging |
| US9180209B2 (en) | 2011-02-28 | 2015-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Non-peptidic quenched fluorescent imaging probes |
| WO2012129128A1 (en) | 2011-03-18 | 2012-09-27 | Biotium, Inc. | Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules |
| US20140249468A1 (en) | 2011-09-09 | 2014-09-04 | The United States Of America,As Represented By The Secretary, Department Of Health And Human Service | Imaging agents for imaging protease activity and uses thereof |
| US20140180073A1 (en) | 2012-12-24 | 2014-06-26 | Anticancer, Inc. | Portable digital imaging system for fluorescence-guided surgery |
| WO2014152389A1 (en) | 2013-03-14 | 2014-09-25 | Lumicell, Inc. | Imaging agent for detection of diseased cells |
| EP4218829A3 (en) * | 2013-03-15 | 2023-08-16 | The Board of Trustees of the Leland Stanford Junior University | Activity-based probe compounds, compositions, and methods of use |
| SG11201508185YA (en) | 2013-04-19 | 2015-11-27 | Agency Science Tech & Res | Tunable fluorescence using cleavable linkers |
| WO2015075699A1 (en) * | 2013-11-25 | 2015-05-28 | Sanofi | Dotam derivatives for therapeutic use |
| CN107406872B (zh) * | 2015-01-22 | 2023-03-28 | 里兰斯坦福初级大学理事会 | 用于标记动物组织的化合物、组合物及其应用 |
| US10288388B1 (en) * | 2015-12-28 | 2019-05-14 | Taser International, Inc. | Methods and apparatus for a cartridge used with a conducted electrical weapon |
-
2018
- 2018-03-30 CN CN201880035357.XA patent/CN110678460A/zh active Pending
- 2018-03-30 EP EP18777788.3A patent/EP3601261A4/en active Pending
- 2018-03-30 WO PCT/US2018/025567 patent/WO2018183960A1/en not_active Ceased
- 2018-03-30 JP JP2019553932A patent/JP7149614B2/ja active Active
- 2018-03-30 KR KR1020197032178A patent/KR102669535B1/ko active Active
- 2018-03-30 US US16/499,734 patent/US11828752B2/en active Active
-
2023
- 2023-10-18 US US18/489,653 patent/US20240077475A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2385066T3 (es) | Péptidos de unión a HGF marcados para la formación de imágenes | |
| JP2018511556A5 (cg-RX-API-DMAC7.html) | ||
| ES2729555T3 (es) | Inhibidores homomultivalentes y heteromultivalentes de antígeno de membrana específico de próstata (PMSA) y usos de los mismos | |
| JP2016518341A5 (cg-RX-API-DMAC7.html) | ||
| ES2736134T3 (es) | Derivado peptídico de tiourea, compuesto marcado con radioisótopos que contiene el mismo y composición farmacéutica que contiene el mismo como ingrediente activo para tratar o diagnosticar el cáncer de próstata | |
| US10278965B2 (en) | Method of detecting cancer stem cell, method of screening cancer stem cell, and method of inhibiting cancer stem cell | |
| EP2849752B1 (en) | Cancer cell inhibitory drug and cancer stem-cell detection probe | |
| ES2476041T3 (es) | Agente citoprotector trifenilfen�lico | |
| JP2003500367A5 (cg-RX-API-DMAC7.html) | ||
| CN105431546A (zh) | 基于活性的探针化合物、组合物及其使用方法 | |
| US20190321313A1 (en) | Benzenesulfonamide derivatives and method for treating cancer | |
| CA2911414A1 (en) | Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging | |
| BR112020019367A2 (pt) | formulação liofilizada, composição farmacêutica, conjunto para a preparação da composição farmacêutica, métodos de preparo de uma formulação liofilizada, de imageamento do corpo mamífero, de detecção, diagnóstico, cirurgia, estadiamento, tratamento, monitoramento de tratamento, monitoramento de progressão de doença ou terapia de monitoramento, de monitoramento de progressão de doença ou terapia de monitoramento de sítios de superexpressão ou localização de cmet, de obtenção de uma imagem de sítios de superexpressão ou localização de cmet, opcionalmente in vivo, e, uso | |
| Murat Canger et al. | Mandibular involvement of solitary plasmocytoma: a case report | |
| JP2021525875A5 (cg-RX-API-DMAC7.html) | ||
| US20030088885A1 (en) | Enhanced resolution of tumor metastasis using a skin flap model | |
| ES2343674T3 (es) | Farmacos preventivos o curativos para el endometriosis. | |
| Fonseca et al. | Ostomy metastasis after pull endoscopic gastrostomy: a unique favorable outcome | |
| JP2020513050A (ja) | in vivo画像化のためのプロテアーゼ活性化コントラスト剤 | |
| JP2004520365A5 (cg-RX-API-DMAC7.html) | ||
| Wada et al. | Leiomyosarcoma in the maxilla: A case report | |
| JP7847538B2 (ja) | フルオロフォア標識upar標的化ペプチドコンジュゲートを含む組成物 | |
| ES2309222T3 (es) | Inhibidores no nucleosidos de la transcriptasa inversa como antagonistas de la proliferacion celular e inductores de la diferenciacion celular. | |
| US20220387632A1 (en) | Renal clearable fluorescent contrast agent with increased tumor specificity, and imaging method using same | |
| CN116917419B (zh) | 用于肿瘤检测和外科手术指导的化合物和组合物 |